Alexander Mulroney
Addressed to: British National Formulary; National Institute for Health and Care Excellence; Medicines and Healthcare products Regulatory Agency
11 of 17 reports addressed to this organisation in the last two years have a response on record from every addressee (65%, against 86% of all reports). This counts reports, not this organisation’s own replies.
Addressed to: British National Formulary; National Institute for Health and Care Excellence; Medicines and Healthcare products Regulatory Agency
Addressed to: Medicines and Healthcare Products Regulatory Agency; Medtronic Limited; University Hospitals of Leicester NHS Trust
Addressed to: Medicines and Healthcare products Regulatory Agency
Addressed to: Association of the British Pharmaceutical Industry; Medicines and Healthcare Products Regulatory Agency; Medicines UK
Addressed to: NHSE; NHS England; [REDACTED], Chief Executive, Medicines and Healthcare Products Regulatory Agency (MHRA), 10 South Colonnade, Canary; [REDACTED], Chief National Medical Examiner, National Medical Examiner’s Office, 6 Alie Street, London E1 8QT
Addressed to: Royal Pharmaceutical Society (RPS); Lewisham and Greenwich NHS Trust; Medicine and Healthcare Product Regulatory Agency; NHS England; Oracle and Cerner; Royal College of Physicians
Addressed to: Croydon University Hospital; Medicines and Healthcare Products Regulatory Agency; Royal College of Emergency Medicine; Royal College of Psychiatrists; Secretary of State for Health & Social Care [REDACTED]; South London & Maudsley NHS Foundation Trust
Addressed to: EMIS Health; Medicines and Healthcare Products Regulatory Agency (MHRA)
Addressed to: Medicines and Healthcare Products Regulatory Agency
Addressed to: Department of Health and Social Care; Medicine and Healthcare Products and Regulatory Agency
Addressed to: Medicines and Healthcare Products Regulatory Agency; Royal College of Radiologists; Department of Health and Social Care; University Hospitals of Northamptonshire NHS Group
Addressed to: Care Quality Commission; Department of Health and Social Care; Medicines and Healthcare Products Regulatory Agency; NHS England; Royal College of Psychiatrists
Addressed to: Devon ICB; Devon Partnership NHS Trust; Medicines and Healthcare Projects; Pembroke Medical Practice
Addressed to: Department for Transport; Medicines & Healthcare products Regulatory Agency
Addressed to: Medicines and Healthcare Products Regulatory Agency; National Institute for Health and Care Excellence; Royal College of General Practitioners
Addressed to: Department for Science, Innovation and Technology; Department of Health and Social Care; Minister of State for Prisons, Parole and Probation; Financial Conduct Authority; Medical and Healthcare Regulatory Authority
Addressed to: Care Quality Commission; Department of Health and Social Care; Medicines, and Healthcare Products Regulatory Agency; NHS England
Addressed to: Care Quality Commission; Medicines and Healthcare Products Regulatory Agency; Red House (Ashtead) Limited
Addressed to: Department of Health and Social Care; Medicines and Healthcare products Regulatory Agency
Addressed to: Barking, Havering and Redbridge University Trust; Department of Health and Social Care; Medicine and Healthcare products Regulatory Agency
Addressed to: Berkshire Integrated Care Board; Community Pharmacy England; General Pharmaceutical Council; Local Pharmacy Commission; Medicines and Healthcare Products Regulatory Agency; National Pharmaceutical Association; NHS Specialist Pharmacy Service; Slough Pharmacy
Addressed to: General Pharmaceutical Council; Lundbeck Limited; Medicines and Healthcare Products Regulatory Agency; National Pharmacy Association
Addressed to: BNF Publications; Department of Health and Social Care; Medicines and Healthcare Products Regulatory Agency
Addressed to: Greater Manchester Health and Social Care Partnership/Integrated Care Board; Medicines and Healthcare Products Regulatory Agency; NHS England; Royal College of Psychiatrists
Addressed to: Medicines and Healthcare products Regulatory Agency